Clinical trial
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With…
NCT00053768 · German High-Grade Non-Hodgkin's Lymphoma Study Group, Other · Completed
Key facts
| NCT number | NCT00053768 |
|---|---|
| Title | Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma |
| Official title | Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Prognoses |
| Lead sponsor | German High-Grade Non-Hodgkin's Lymphoma Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, EPOCH regimen, cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisone, vincristine sulfate, radiation therapy |
| Enrollment | 392 |
| Start date | Apr 1, 2002 |
| Primary completion | Dec 5, 2006 |
| Completion | Dec 5, 2006 |
| First posted | Feb 6, 2003 |
| Last update posted | May 18, 2021 |
| Countries | Germany, Switzerland |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: